American Society of Hirudotherapy

Controversy: hirudotherapy (leech therapy) as an alternative treatment for osteoarthritis

Research article published in Acta medica Indonesiana (2015)

Last Updated: March 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Clinical TrialsGunawan F et al. · Acta medica Indonesiana, 2015

Abstract

Osteoarthritis (OA) is the most common degenerative joint disease found in the elderly. Drug options that are recommended by the American Academy of Orthopaedic Surgeon (AAOS) are acetaminophen, NSAIDs, tramadol, capscaicin and intraarticular corticosteroids. However, there is concern for the possible side effects resulting from long term use of those medications. Researchers are searching for a safer treatment modality for OA. Leech therapy (hirudotheraphy) is one of the therapies under investigation, given its purported analgesic and antiinflammatory properties.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAcetaminophenAgedAnti-Inflammatory Agents, Non-SteroidalComplementary TherapiesHumansIndonesiaLeechingOsteoarthritisRandomized Controlled Trials as TopicTreatment Outcome

Summary

Osteoarthritis (OA) is the most common degenerative joint disease found in the elderly. Drug options that are recommended by the American Academy of Orthopaedic Surgeon (AAOS) are acetaminophen, NSAIDs, tramadol, capscaicin and intraarticular corticosteroids.

Why This Matters for Hirudotherapy

Contributes clinical evidence for the therapeutic application of leech therapy.

Citation

Controversy: hirudotherapy (leech therapy) as an alternative treatment for osteoarthritis.

Gunawan F et al. · Acta medica Indonesiana, 2015

Added to ASH library: March 18, 2026 · Site last updated: March 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Controversy: hirudotherapy (leech therapy) as an alternative treatment for osteoarthritis | ASH